UroGen to conduct Botox trial with Allergan
Related Biotechnology, Pharmaceutical and Healthcare News
The trial will use delayed release Botox to treat overactive bladder syndrome.
Original Article: UroGen to conduct Botox trial with Allergan
NEXT ARTICLE
More From BioPortfolio on "UroGen to conduct Botox trial with Allergan"